90 related articles for article (PubMed ID: 18639901)
21. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
Kapustin VV
Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
[TBL] [Abstract][Full Text] [Related]
22. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels.
Yang JC; Tang J; Li J; Luo Y; Li Y; Shi H
Acad Radiol; 2008 Oct; 15(10):1291-7. PubMed ID: 18790401
[TBL] [Abstract][Full Text] [Related]
24. Initial experiences with real-time elastography guided biopsies of the prostate.
König K; Scheipers U; Pesavento A; Lorenz A; Ermert H; Senge T
J Urol; 2005 Jul; 174(1):115-7. PubMed ID: 15947593
[TBL] [Abstract][Full Text] [Related]
25. [Current value of transrectal fine needle biopsy. High predictive value in the diagnosis of prostate carcinoma, minimal discomfort to the patient].
Cullmann HJ
Fortschr Med; 1991 Sep; 109(26):518-20. PubMed ID: 1783343
[TBL] [Abstract][Full Text] [Related]
26. Improved prostate cancer detection with anterior apical prostate biopsies.
Wright JL; Ellis WJ
Urol Oncol; 2006; 24(6):492-5. PubMed ID: 17138129
[TBL] [Abstract][Full Text] [Related]
27. Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
Ng CF; Chan SY
J Urol; 2008 Oct; 180(4):1570-1; author reply 1571. PubMed ID: 18718610
[No Abstract] [Full Text] [Related]
28. Directed and random biopsies of the prostate: indications based on combined results of transrectal sonography and prostate-specific antigen density determinations.
Olson MC; Posniak HV; Fisher SG; Flisak ME; Salomon CG; Flanigan RC; Waters WB; Pyle JM
AJR Am J Roentgenol; 1994 Dec; 163(6):1407-11. PubMed ID: 7527614
[TBL] [Abstract][Full Text] [Related]
29. [The diagnostic effectiveness of repeat echo-guided transrectal biopsy as a function of the clinical and anatomicopathological findings].
Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bueno Chomón G; Leal Hernández F; Bielsa Carrillo A; García Burgos J
Actas Urol Esp; 1999 May; 23(5):394-9. PubMed ID: 10427812
[TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions.
Mitterberger M; Pelzer A; Colleselli D; Bartsch G; Strasser H; Pallwein L; Aigner F; Gradl J; Frauscher F
Eur J Radiol; 2007 Nov; 64(2):231-8. PubMed ID: 17881175
[TBL] [Abstract][Full Text] [Related]
31. Optimal site and number of biopsy cores according to prostate volume prostate cancer detection in Korea.
Shim HB; Park HK; Lee SE; Ku JH
Urology; 2007 May; 69(5):902-6. PubMed ID: 17482931
[TBL] [Abstract][Full Text] [Related]
32. A national survey of transrectal ultrasound-guided prostatic biopsies: time for a national guideline.
Patel HR; Lee F; Arya M; Masood S; Palmer JH; Sheriff MK
Int J Clin Pract; 2003 Nov; 57(9):773-4. PubMed ID: 14686566
[TBL] [Abstract][Full Text] [Related]
33. [Puncture biopsy of the prostate].
Lechevallier E
Prog Urol; 1996; 6(4):507-18. PubMed ID: 8924925
[TBL] [Abstract][Full Text] [Related]
34. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
[TBL] [Abstract][Full Text] [Related]
35. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
36. The continuing importance of transrectal ultrasound identification of prostatic lesions.
Toi A; Neill MG; Lockwood GA; Sweet JM; Tammsalu LA; Fleshner NE
J Urol; 2007 Feb; 177(2):516-20. PubMed ID: 17222623
[TBL] [Abstract][Full Text] [Related]
37. Systematic prostate biopsies are more and more often becoming saturation biopsies.
Scattoni V
Eur Urol; 2006 Aug; 50(2):202-4. PubMed ID: 16488531
[No Abstract] [Full Text] [Related]
38. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer.
Norberg M; Egevad L; Holmberg L; Sparén P; Norlén BJ; Busch C
Urology; 1997 Oct; 50(4):562-6. PubMed ID: 9338732
[TBL] [Abstract][Full Text] [Related]
39. Re: Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.
Yuen JS
J Urol; 2003 Jul; 170(1):192-3; author reply 193. PubMed ID: 12796685
[No Abstract] [Full Text] [Related]
40. [Omission factors in detecting early stage prostate cancer by TRUS needle biopsy].
Zhang SW; Guo HQ; Gan WD; Gong ZH; Sun ZY
Zhonghua Nan Ke Xue; 2005 Jun; 11(6):431-2, 437. PubMed ID: 15999487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
